Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Shares | 100.000 | 100.000 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 19.868 | 19.570 |
| Price to Book | 4.726 | 3.777 |
| Price to Sales | 2.483 | 2.182 |
| Price to Cash Flow | 15.915 | 14.572 |
| Dividend Yield | 2.344 | 1.490 |
| 5 Years Earnings Growth | 12.351 | 9.859 |
| Name | Net % | Category Average |
|---|---|---|
| Healthcare | 96.720 | 94.890 |
| Industrials | 2.410 | 2.752 |
| Consumer Defensive | 0.870 | 3.041 |
Number of long holdings: 43
Number of short holdings: 0
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| UnitedHealth | US91324P1021 | 10.37 | 360.45 | -0.29% | |
| Roche Holding Participation | CH0012032048 | 7.98 | 272.80 | +0.44% | |
| Novo Nordisk A/S Class B | DK0060534915 | 5.99 | - | - | |
| Amgen | US0311621009 | 5.68 | 292.89 | -1.04% | |
| Vertex | US92532F1003 | 5.20 | 422.63 | -0.89% | |
| Elevance Health | US0367521038 | 4.67 | 346.28 | +0.31% | |
| Pfizer | US7170811035 | 4.32 | 24.67 | -0.20% | |
| GlaxoSmithKline PLC | GB0009252882 | 4.17 | - | - | |
| Zoetis Inc | US98978V1035 | 3.74 | 146.39 | -0.49% | |
| Cigna | US1255231003 | 3.40 | 305.07 | -0.91% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| AB FCP IAmericanGrwthPf A EUR H Acc | 7.42B | 10.27 | 22.08 | 13.03 | ||
| AB FCP IAmericanGrwthPf I EUR H Acc | 7.42B | 10.94 | 23.04 | 13.94 | ||
| AB FCP IAmericanGrwthPf C EUR H Acc | 7.42B | 9.90 | 21.53 | 12.52 | ||
| Japan Strategic Value Portfolio S1e | 7.34B | 17.43 | 2.82 | 8.48 | ||
| AB FCP IJapStratValuePrtfloI AccEUR | 6.7B | 3.87 | 9.29 | 10.31 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review